359 related articles for article (PubMed ID: 19298697)
1. Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice.
Biala G; Kruk M
J Pharm Pharmacol; 2009 Apr; 61(4):493-502. PubMed ID: 19298697
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel antagonists suppress cross-tolerance to the anxiogenic effects of D-amphetamine and nicotine in the mouse elevated plus maze test.
Biala G; Kruk M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):54-61. PubMed ID: 17761379
[TBL] [Abstract][Full Text] [Related]
3. Effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in mice.
Carrasco MC; Vicens P; Vidal J; Redolat R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):455-62. PubMed ID: 16413646
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice.
Carrasco MC; Vicens P; Vidal J; Redolat R
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1135-41. PubMed ID: 15610926
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic nicotine on elevated plus maze in mice: involvement of calcium channels.
Biala G; Budzynska B
Life Sci; 2006 May; 79(1):81-8. PubMed ID: 16458932
[TBL] [Abstract][Full Text] [Related]
6. Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test.
Biala G; Kruk M; Budzynska B
J Physiol Pharmacol; 2009 Jun; 60(2):113-22. PubMed ID: 19617654
[TBL] [Abstract][Full Text] [Related]
7. Conditioned anxiety to nicotine.
File SE; Cheeta S; Irvine EE; Tucci S; Akthar M
Psychopharmacology (Berl); 2002 Nov; 164(3):309-17. PubMed ID: 12424555
[TBL] [Abstract][Full Text] [Related]
8. Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats.
Zarrindast MR; Solati J; Oryan S; Parivar K
Pharmacology; 2008; 82(4):276-84. PubMed ID: 18849647
[TBL] [Abstract][Full Text] [Related]
9. Effects of amphetamine on the plus-maze discriminative avoidance task in mice.
Silva RH; Kameda SR; Carvalho RC; Rigo GS; Costa KL; Taricano ID; Frussa-Filho R
Psychopharmacology (Berl); 2002 Feb; 160(1):9-18. PubMed ID: 11862369
[TBL] [Abstract][Full Text] [Related]
10. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory.
Wall PM; Messier C
Psychopharmacology (Berl); 2002 Mar; 160(3):233-44. PubMed ID: 11889492
[TBL] [Abstract][Full Text] [Related]
11. Amphetamine and pentylenetetrazole given post-trial 1 enhance one-trial tolerance to the anxiolytic effect of diazepam in the elevated plus-maze in mice.
Vargas KM; Da Cunha C; Andreatini R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1394-402. PubMed ID: 16828217
[TBL] [Abstract][Full Text] [Related]
12. Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms.
Chae Y; Yeom M; Han JH; Park HJ; Hahm DH; Shim I; Lee HS; Lee H
Neurosci Lett; 2008 Jan; 430(2):98-102. PubMed ID: 18060697
[TBL] [Abstract][Full Text] [Related]
13. Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs.
Hayase T
BMC Neurosci; 2007 Sep; 8():76. PubMed ID: 17877812
[TBL] [Abstract][Full Text] [Related]
14. Effects of bupropion, alone or coadministered with nicotine, on social behavior in mice.
Gómez C; Carrasco C; Redolat R
Addict Biol; 2008 Sep; 13(3-4):301-9. PubMed ID: 18331371
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant- and anxiolytic-like activity of magnesium in mice.
Poleszak E; Szewczyk B; Kedzierska E; Wlaź P; Pilc A; Nowak G
Pharmacol Biochem Behav; 2004 May; 78(1):7-12. PubMed ID: 15159129
[TBL] [Abstract][Full Text] [Related]
16. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice.
Celik E; Uzbay IT; Karakas S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):50-5. PubMed ID: 16084635
[TBL] [Abstract][Full Text] [Related]
17. Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion.
Semba J; Wakuta M
Psychiatry Clin Neurosci; 2008 Aug; 62(4):435-41. PubMed ID: 18778441
[TBL] [Abstract][Full Text] [Related]
18. Anxiety-like behavior during nicotine withdrawal predict subsequent nicotine consumption in adolescent C57BL/6 mice.
Manhães AC; Guthierrez MC; Filgueiras CC; Abreu-Villaça Y
Behav Brain Res; 2008 Nov; 193(2):216-24. PubMed ID: 18573281
[TBL] [Abstract][Full Text] [Related]
19. Amphetamine- and nicotine-induced cross-sensitization in adolescent rats persists until adulthood.
Santos GC; Marin MT; Cruz FC; Delucia R; Planeta CS
Addict Biol; 2009 Jul; 14(3):270-5. PubMed ID: 19523043
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
